Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Salgia, Ravi
One or more keywords matched the following items that are connected to
Salgia, Ravi
Item Type
Name
Academic Article
EGFR-targeted therapeutics: focus on SCCHN and NSCLC.
Academic Article
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Academic Article
AXL mediates resistance to cetuximab therapy.
Academic Article
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Academic Article
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Academic Article
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Academic Article
RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Academic Article
Refining epidermal growth factor receptor (EGFR) -inhibition-related rash (EIRR) phenotypes with a cetuximab (C) monotherapy stage of a phase II trial for non-small cell lung cancer (NSCLC).
Academic Article
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer.
Academic Article
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Concept
Cetuximab
Search Criteria
Cetuximab